OSE Pharma SA (OSE) — Cash Flow-to-Debt Ratio
OSE Pharma SA (OSE) has a Cash Flow-to-Debt Ratio of -0.34x as of June 2025, meaning its operating cash flow of €-17.98 Million could theoretically repay 0% of its total liabilities (€53.58 Million) in one year. See how much free cash does OSE Pharma SA generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
OSE Pharma SA Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for OSE Pharma SA across 13 annual periods. Also explore OSE Pharma SA annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for OSE Pharma SA (2012–2024)
Year-by-year debt coverage analysis for OSE Pharma SA. For market capitalisation and broader financial context, see market cap of OSE Pharma SA.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.81x | €48.44 Million | €60.15 Million | ▲ +340.7% |
| 2023 | -0.33x | €-19.76 Million | €59.08 Million | ▼ -8.4% |
| 2022 | -0.31x | €-18.25 Million | €59.12 Million | ▼ -68.0% |
| 2021 | -0.18x | €-9.92 Million | €53.99 Million | ▲ +66.5% |
| 2020 | -0.55x | €-19.55 Million | €35.61 Million | ▼ -286.0% |
| 2019 | 0.30x | €8.97 Million | €30.40 Million | ▲ +315.1% |
| 2018 | 0.07x | €1.08 Million | €15.15 Million | ▲ +119.5% |
| 2017 | -0.36x | €-8.00 Million | €21.91 Million | ▼ -1435.2% |
| 2016 | 0.03x | €684.00K | €25.02 Million | ▲ +101.5% |
| 2015 | -1.83x | €-4.61 Million | €2.52 Million | ▼ -163.2% |
| 2014 | -0.70x | €-1.94 Million | €2.78 Million | ▼ -253.9% |
| 2013 | -0.20x | €-236.00K | €1.20 Million | ▲ +87.1% |
| 2012 | -1.52x | €-1.39 Million | €915.00K | — |